Latest News and Press Releases

Austin, TX, USA, June 26, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “In Silico Clinical Trials Market Size, Trends and Insights By Component...

Part C domestic enrollment is underway at three clinical sites in the U.S. CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a...

New York, USA, June 24, 2026 (GLOBE NEWSWIRE) -- Global HPV Vaccines Market to Grow Rapidly at a CAGR of ~8% by 2034 | DelveInsight The HPV vaccines market is witnessing significant growth due to...

NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group LLC (NASDAQ: SAMG) today announced that its Global Value Opportunity Fund has received a ‘Recommended’ rating from...

AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Oncology research is moving through one of its most active stretches in years. DNA Damage Response (“DDR”) inhibitors,...

OCALA, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today highlighted the significant progress achieved across its pancreatic cancer...

REDWOOD CITY, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (Nasdaq: CHRS) and Zumutor Biologics Inc. (“Zumutor”), an immuno-oncology biotech company, today announced a clinical...

GAINESVILLE, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- X-tosis Receives Grant from The Michael J. Fox Foundation for Parkinson’s Research to Advance Novel Parkinson's Disease Therapy. The ward...

AUSTIN, Texas, June 22, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Cancer research is entering one of its most dynamic periods in decades. The class of drugs known as DNA Damage...

The planned Phase 3 trial in approximately 750 postmenopausal women with osteoporosis, with a primary endpoint of total hip bone mineral density (BMD) at Month 12, would support Entera’s plan to...